En vivo
10x Genomics BlogLiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor - BioSpaceThermo FisherThermo Fisher Scientific: Why A Slow Q1 Does Not Reflect The Growth Opportunities - Seeking AlphaMOONS'How Artemis will help the U.S. create a moon base - NBC NewsAgilentAgilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocusThermo FisherThermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatchFierceBiotechDespite data concerns, Roche’s oral SERD can still be largest product in company history: execFierceBiotechRegeneron ushers in new genetic medicine era with groundbreaking gene therapy approvalThermo FisherThermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - StockStoryAgilentEarnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSNThermo FisherThermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - TradingView
Endpoints News 26 dic 2025

Biohaven’s ion channel drug fails again, this time in major depressive disorder

Biohaven’s ion channel drug fails again, this time in major depressive disorder

Original
Contenido no disponible. Consulta la fuente original.